Minimize development time with efficient design and optimization of all genetic components of your potential biotherapeutic. Confirm and optimize gene edits and functional vector elements at high- or low-throughput with highly specific gene expression, qPCR, and sequencing. Genetic variant analysis and highly sensitive dPCR can help to establish optimum therapeutic titration and identify even low levels of pathogen contaminants.
Streamline exploration of large libraries of constructs to explore genetic variants associated with genetic regulation of and response to your biopharmaceutical.
Transform development of new therapeutic approaches with gene knock-down and knock-up investigations and optimize performance with validated indels and variants.
In this conversation with Dr. Darren Roberts, he discusses challenges in conducting gene expression studies with DNA and RNA from FFPE tumor tissues. He also explains the importance of selecting the right technology for each sample and stage in the process.
Efficiently develop and characterize recombinant monoclonal antibodies (mAbs) from discovery through clinical trials and manufacturing by incorporating genetic-level analysis into your workflows.